← Back to Search

Green and White LED Light Therapy for Chronic Pain

N/A

Waitlist Available

Led By Mohab Ibrahim, PhD., MD

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Peripheral neuropathy from HIV or chemotherapy.

Peripheral neuropathy from HIV or chemotherapy

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 10 - 22 weeks, depending on study arm

Awards & highlights

Study Summary

This trial is investigating whether or not light therapy can be used as a pain management technique for chronic pain sufferers.

Who is the study for?

This trial is for adults aged 18-80 with chronic pain, such as fibromyalgia or peripheral neuropathy from HIV/chemotherapy, who have a pain score of at least 5/10. Participants must understand English and follow the study plan. It's not for those incarcerated, unable to read English, paid for their pain treatment, or with addiction issues or severe depression.Check my eligibility

What is being tested?

The trial tests if green LED light therapy can reduce chronic pain better than white LED light (control). Participants will use their assigned LED lights in a dark room for two hours daily over three months. The study aims to see if this reduces the need for painkillers and improves life quality.See study design

What are the potential side effects?

LED light therapy is considered safe; however, potential side effects are not detailed in this summary. Generally, light therapy may cause eye strain or headache but typically has fewer side effects compared to pharmacological treatments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have nerve pain or tingling from HIV or chemotherapy.

Select...

I have nerve pain or tingling from HIV or chemotherapy.

Select...

My average pain level is 5 or more out of 10.

Select...

I have been diagnosed with fibromyalgia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 10 - 22 weeks, depending on study arm

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~10 - 22 weeks, depending on study arm

This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 - 22 weeks, depending on study arm for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

For fibromyalgia pain.

For migraine headache pain.

Secondary outcome measures

Ability to Do Chores

Ability to Excersize

Ability to Fall Asleep

+15 more

Trial Design

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Exposure to green LED lightExperimental Treatment1 Intervention

Subjects will exposed to green light provided to them, in their homes in a dark room for approximately 2 hours for 10 weeks.

Group II: Cross overExperimental Treatment2 Interventions

Subject will be exposed to white light (sham) for 10 weeks, then have a wash out period for 2 weeks, then exposed to green light (experimental) for 10 weeks.

Group III: Exposure to white LED light.Placebo Group1 Intervention

Subjects will exposed to white light provided to them, in their homes in a dark room for approximately 2 hours for 10 weeks

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor

514 Previous Clinical Trials

148,213 Total Patients Enrolled

5 Trials studying Chronic Pain

1,422 Patients Enrolled for Chronic Pain

Mohab Ibrahim, PhD., MDPrincipal Investigator - University of Arizona

Banner-University Medical Center South

University Of Arizona College Of Medicine (Medical School)

Media Library

Light Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03677206 — N/A

Chronic Pain Research Study Groups: Exposure to white LED light., Exposure to green LED light, Cross over

Chronic Pain Clinical Trial 2023: Light Therapy Highlights & Side Effects. Trial Name: NCT03677206 — N/A

Light Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03677206 — N/A

Chronic Pain Patient Testimony for trial: Trial Name: NCT03677206 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What ultimate goals are researchers hoping to achieve with this clinical trial?

"The primary outcome of the research, which will be determined within a 10 to 22 week period depending on the arm, seeks to measure migraine headache pain. Secondary objectives include Pain Intensity (subjectively reported by patients in a 0-100% scale), Pain Episode Duration (also subjectively reported in a 0-100% scale) and Ability to Work (once again subjectively assessed through patient reportage with a 0-100% range)."

Answered by AI

Is it feasible to partake in this clinical investigation?

"This clinical trial is aiming to recruit 60 participants with chronic pain from ages 18 through 80. All applicants must have a history of fibromyalgia, an average numeric pain score of 5/10 or above at baseline evaluation, peripheral neuropathy due to HIV or chemotherapy treatments, and experience headaches and other forms of ongoing discomfort."

Answered by AI

Is participation in the trial open to geriatric individuals?

"This research study is welcoming individuals aged 18 and above, to a maximum of 80 years old."

Answered by AI

What is the total number of participants currently involved in this trial?

"Affirmative, the information available on clinicaltrials.gov suggests that this investigation is recruiting participants. The trial was initially posted on June 1st 2016 and most recently updated on November 7th 2022. 60 patients must be recruited from a single site for successful completion of the study."

Answered by AI

Are recruitment efforts currently underway for this clinical investigation?

"That is correct. According to clinicaltrials.gov, this experiment began recruiting on June 1st 2016 and was recently edited in November 2022. 60 patients are necessary for the trial at a single research site."

Answered by AI